Ritu Bansal, MD
Hospitalist · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 2
- Since medical school
- 22 years
- Graduated 2004
Offices
2 locations · University of California San Francisco · Regents of the University of California
Hospitals listed: UCSF Health Stanyan Hospital · UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bansal’s office at (415) 476-4029 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A101750 · Current
Licensed to practise in California · since 2007 · expires 2027-03-31 · University of Mumbai, Mahatma Gandhi Mission'S Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Health St. Mary'S HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Health St. Mary'S Hospital
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 413 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.58 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 146.74 (92.54 to 200.93) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 220 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.3 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,363 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 2,530 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.02 (0.73 to 5.31) · 590 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.35) · 238 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (0.43 to 3.7) · 554 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.7 (4.19 to 21.21) · 259 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.67 (1.51 to 9.83) · 203 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.99) · 2,258 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 158 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 61 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 291 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.4 · 251 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 5.5 · 189 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 213 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.5) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12 (8.3 to 17.1) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 176 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 61 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.8) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 113 cases | No different | Jan 2024 – Dec 2024 |
What patients said (587 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$29,344
Medicare paid this office $29,344 for 141 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 64 | $16,579 | $104 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $3,534 | $154 |
| Hospital discharge day management, more than 30 minutes | 29 | $3,009 | $104 |
| Removal of cerebrospinal fluid with lower back spinal tap for diagnostic test | 13 | $689 | $53 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Aspiration of fluid from chest cavity using imaging guidance | – | – | – | – | 16 | – |
| Removal of cerebrospinal fluid with lower back spinal tap for diagnostic test | – | – | – | – | – | 13 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
141 Original Medicare patients in 2024. Average age 76 · Under 65 14% · 85 and older 28% · Women 52% · Also on Medicaid 60% · Health risk score 3.32. Sicker patients than 9 in 10 peers; the typical hospitalist clinician is at 2.49.
Conditions among them: High blood pressure 75% · Chronic kidney disease 56% · Coronary heart disease 49% · Diabetes 47% · Heart failure 45% · Depression 44% · Atrial fibrillation 39% · Dementia 30% · Stroke 26% · COPD 24% · Cancer 22%.
The office billed $244,586, Medicare allowed $36,995 and paid $29,344; for 310 services of 20 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 141 | 310 | 76 | 3.32 | $244,586 | $29,344 |
| 2023 | 185 | 523 | 76 | 3.07 | $364,773 | $47,355 |
| 2022 | 179 | 546 | 77 | 2.46 | $290,882 | $46,180 |
| 2021 | 15 | 25 | 72 | 3.06 | $4,192 | $1,429 |
| 2020 | 20 | 39 | 76 | 3.53 | $6,549 | $2,751 |
| 2019 | 17 | 35 | 70 | 2.26 | $6,541 | $2,222 |
| 2018 | 14 | 30 | 73 | 3.21 | $5,847 | $2,018 |
| 2017 | 21 | 31 | 69 | 2.21 | $6,296 | $2,109 |
| 2016 | 15 | 20 | 71 | 3.51 | $4,716 | $1,272 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 77 | $20,039 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 61 | $10,943 | $70 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $5,130 | $151 |
| Hospital discharge day management, more than 30 minutes | 36 | $3,713 | $100 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,768 | $110 |
| Aspiration of fluid from chest cavity using imaging guidance | 16 | $1,515 | $95 |
| Hospital discharge day management, 30 minutes or less | 18 | $1,257 | $70 |
2022: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 98 | $24,316 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 62 | $8,796 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,003 | $174 |
| Hospital discharge day management, 30 minutes or less | 51 | $3,351 | $64 |
| Hospital discharge day management, more than 30 minutes | 26 | $2,460 | $95 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,775 | $118 |
2020: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,501 | $65 |
2019: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,867 | $64 |
Medicaid work
$3,212 in 2024
Medicaid paid $3,212 for 24 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 24 | $3,212 |
| 2024 | 24 | 1 | 12 | $3,212 |
| 2023 | 21 | 1 | 13 | $1,503 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 21 | $1,503 |
Drugs they prescribed that Part D paid
$1,954
Pharmacies billed $1,954 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
43 generic and 18 brand-name prescriptions · $1,954 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Adacel Tdap | 13 | $663 | $51 |
Year by year
| 2024 | 61 | 36 | None | 30% | $1,954 |
| 2023 | 149 | 58 | None | None | $14,050 |
| 2022 | 208 | 81 | None | None | $17,822 |
| 2021 | 334 | 115 | 4% (12) | None | $17,966 |
| 2020 | 381 | 136 | 3% (13) | None | $24,359 |
| 2019 | 609 | 184 | 3% (20) | None | $35,391 |
| 2018 | 490 | 169 | 4% (18) | None | $26,577 |
| 2017 | 620 | 212 | 4% (27) | None | $29,816 |
| 2016 | 1,100 | 335 | 2% (17) | 25% | $48,900 |
| 2015 | 3,192 | 473 | 3% (89) | 25% | $151,981 |
| 2014 | 3,495 | 548 | 6% (201) | 21% | $147,877 |
| 2013 | 3,310 | 564 | 6% (208) | 20% | $152,775 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 4 drugs
| Adacel Tdap | 16 | $816 | $51 |
| Metoprolol | 13 | $214 | $16 |
| Pantoprazole | 11 | $137 | $12 |
| Furosemide | 12 | $115 | $10 |
2021: 3 drugs
| Furosemide | 38 | $463 | $12 |
| Doxycycline Monohydrate | 17 | $187 | $11 |
| Warfarin | 12 | $140 | $12 |
2020: 7 drugs
| Furosemide | 31 | $387 | $12 |
| Atorvastatin | 15 | $265 | $18 |
| Cefpodoxime Proxetil | 16 | $229 | $14 |
| Pantoprazole | 13 | $179 | $14 |
| Doxycycline Monohydrate | 15 | $132 | $9 |
| Metoprolol | 11 | $122 | $11 |
| Cephalexin | 11 | $81 | $7 |
2019: 13 drugs
| Cefpodoxime Proxetil | 37 | $807 | $22 |
| Furosemide | 53 | $612 | $12 |
| Ventolin Hfa | 11 | $529 | $48 |
| Atorvastatin | 22 | $477 | $22 |
| Pantoprazole | 23 | $455 | $20 |
| Doxycycline Monohydrate | 40 | $393 | $10 |
| Metoprolol | 30 | $257 | $9 |
| Tamsulosin | 15 | $253 | $17 |
| Prednisone | 24 | $234 | $10 |
| Cephalexin | 16 | $159 | $10 |
| Omeprazole | 11 | $152 | $14 |
| Amlodipine Besylate | 11 | $98 | $9 |
| Glipizide | 13 | $97 | $7 |
2018: 12 drugs
| Atorvastatin | 26 | $643 | $25 |
| Pantoprazole | 16 | $499 | $31 |
| Cefpodoxime Proxetil | 20 | $375 | $19 |
| Furosemide | 32 | $345 | $11 |
| Prednisone | 29 | $284 | $10 |
| Tamsulosin | 13 | $231 | $18 |
| Doxycycline Monohydrate | 25 | $227 | $9 |
| Cephalexin | 13 | $168 | $13 |
| Omeprazole | 13 | $162 | $12 |
| Amoxicillin-Clavulanate Potass | 11 | $148 | $13 |
| Metoprolol | 17 | $120 | $7 |
| Lisinopril | 11 | $88 | $8 |
2017: 17 drugs
| Spiriva Respimat | 16 | $4,212 | $263 |
| Atorvastatin | 29 | $837 | $29 |
| Cefpodoxime Proxetil | 17 | $812 | $48 |
| Pantoprazole | 25 | $525 | $21 |
| Hydralazine | 21 | $386 | $18 |
| Furosemide | 29 | $312 | $11 |
| Glipizide | 22 | $239 | $11 |
| Fluticasone Propionate | 18 | $235 | $13 |
| Alendronate | 16 | $227 | $14 |
| Amoxicillin-Clavulanate Potass | 14 | $220 | $16 |
| Cephalexin | 18 | $195 | $11 |
| Doxycycline Monohydrate | 18 | $191 | $11 |
| Simvastatin | 12 | $179 | $15 |
| Warfarin | 13 | $170 | $13 |
| Metformin | 13 | $150 | $12 |
| Metoprolol | 17 | $139 | $8 |
| Prednisone | 15 | $129 | $9 |
2016: 27 drugs
| Spiriva Respimat | 21 | $6,033 | $287 |
| Dulera | 12 | $3,172 | $264 |
| Atorvastatin | 76 | $2,201 | $29 |
| Humulin N | 14 | $2,196 | $157 |
| Cefpodoxime Proxetil | 24 | $1,747 | $73 |
| Hydralazine | 30 | $1,411 | $47 |
| Levothyroxine | 28 | $1,009 | $36 |
| Simvastatin | 33 | $660 | $20 |
| Furosemide | 56 | $606 | $11 |
| Pantoprazole | 21 | $597 | $28 |
| Omeprazole | 18 | $527 | $29 |
| Lisinopril | 49 | $521 | $11 |
| Amlodipine Besylate | 32 | $482 | $15 |
| Metformin | 41 | $468 | $11 |
| Losartan | 19 | $453 | $24 |
| Fluticasone Propionate | 27 | $386 | $14 |
| Atenolol | 32 | $384 | $12 |
| Glipizide | 31 | $332 | $11 |
| Alendronate | 22 | $328 | $15 |
| Warfarin | 26 | $300 | $12 |
| Metoprolol | 33 | $285 | $9 |
| Hydrochlorothiazide | 24 | $273 | $11 |
| Lisinopril-Hydrochlorothiazide | 19 | $230 | $12 |
| Lovastatin | 18 | $227 | $13 |
| Fluoxetine | 11 | $182 | $17 |
| Doxycycline Monohydrate | 11 | $136 | $12 |
| Azithromycin | 13 | $131 | $10 |
2015: 55 drugs
| Spiriva | 33 | $16,198 | $491 |
| Atorvastatin | 285 | $8,717 | $31 |
| Dulera | 20 | $6,545 | $327 |
| Hydralazine | 49 | $4,220 | $86 |
| Levothyroxine | 118 | $4,178 | $35 |
| Humulin N | 25 | $3,576 | $143 |
| Amlodipine Besylate | 148 | $3,019 | $20 |
| Losartan | 96 | $2,687 | $28 |
| Omeprazole | 60 | $2,628 | $44 |
| Simvastatin | 128 | $2,415 | $19 |
| Zostavax | 11 | $2,145 | $195 |
| Atenolol | 163 | $1,966 | $12 |
| Pantoprazole | 50 | $1,840 | $37 |
| Lisinopril | 156 | $1,791 | $11 |
| Gabapentin | 18 | $1,783 | $99 |
| Klor-Con 8 | 19 | $1,682 | $89 |
| Allopurinol | 31 | $1,626 | $52 |
| Qvar | 18 | $1,444 | $80 |
| Fluticasone Propionate | 58 | $1,295 | $22 |
| Hydrochlorothiazide | 118 | $1,281 | $11 |
| Hydrocodone-Acetaminophen | 26 | $1,266 | $49 |
| Losartan-Hydrochlorothiazide | 41 | $1,246 | $30 |
| Tamsulosin | 21 | $1,196 | $57 |
| Lisinopril-Hydrochlorothiazide | 85 | $1,120 | $13 |
| Montelukast | 24 | $1,105 | $46 |
| Metformin | 93 | $1,084 | $12 |
| Proair Hfa | 34 | $1,057 | $31 |
| Glipizide | 81 | $1,013 | $13 |
| Insulin | 20 | $951 | $48 |
| Lovastatin | 70 | $879 | $13 |
| Metoprolol | 90 | $848 | $9 |
| Oxycodone-Acetaminophen | 16 | $702 | $44 |
| Furosemide | 57 | $677 | $12 |
| Famotidine | 34 | $654 | $19 |
| Clopidogrel | 13 | $645 | $50 |
| Alendronate | 39 | $581 | $15 |
| Ibuprofen | 20 | $531 | $27 |
| Acetaminophen-Codeine | 17 | $527 | $31 |
| Morphine Sulfate Er | 11 | $524 | $48 |
| Tramadol Hcl-Acetaminophen | 12 | $450 | $37 |
| Naproxen | 20 | $442 | $22 |
| Fluoxetine | 31 | $401 | $13 |
| Terazosin | 24 | $360 | $15 |
| Lorazepam | 26 | $284 | $11 |
| Temazepam | 11 | $262 | $24 |
| Warfarin | 20 | $248 | $12 |
| Clonidine | 12 | $233 | $19 |
| Carvedilol | 19 | $212 | $11 |
| Trazodone | 17 | $187 | $11 |
| Meloxicam | 16 | $161 | $10 |
| Ciprofloxacin | 17 | $145 | $9 |
| Cephalexin | 12 | $132 | $11 |
| Azithromycin | 11 | $130 | $12 |
| Metformin Hcl Er | 12 | $124 | $10 |
| Spironolactone | 12 | $107 | $9 |
2014: 63 drugs
| Spiriva | 29 | $12,580 | $434 |
| Atorvastatin | 235 | $7,455 | $32 |
| Dulera | 21 | $5,742 | $273 |
| Hydralazine | 49 | $3,409 | $70 |
| Levothyroxine | 134 | $3,256 | $24 |
| Losartan | 99 | $2,951 | $30 |
| Amlodipine Besylate | 152 | $2,909 | $19 |
| Gabapentin | 26 | $2,861 | $110 |
| Simvastatin | 137 | $2,614 | $19 |
| Humulin N | 22 | $2,526 | $115 |
| Omeprazole | 61 | $2,470 | $40 |
| Hydrocodone-Acetaminophen | 112 | $2,462 | $22 |
| Zostavax | 13 | $2,405 | $185 |
| Humulin 70-30 | 12 | $2,176 | $181 |
| Atenolol | 179 | $2,169 | $12 |
| Klor-Con 8 | 16 | $1,917 | $120 |
| Lisinopril | 162 | $1,849 | $11 |
| Pantoprazole | 51 | $1,847 | $36 |
| Qvar | 23 | $1,787 | $78 |
| Fluticasone Propionate | 68 | $1,623 | $24 |
| Morphine Sulfate Er | 24 | $1,512 | $63 |
| Hydrochlorothiazide | 129 | $1,417 | $11 |
| Fenofibrate | 15 | $1,313 | $88 |
| Lisinopril-Hydrochlorothiazide | 101 | $1,146 | $11 |
| Pravastatin | 19 | $1,123 | $59 |
| Allopurinol | 33 | $1,108 | $34 |
| Montelukast | 18 | $1,050 | $58 |
| Losartan-Hydrochlorothiazide | 31 | $999 | $32 |
| Proair Hfa | 30 | $979 | $33 |
| Glipizide | 72 | $965 | $13 |
| Metformin | 85 | $954 | $11 |
| Acetaminophen-Codeine | 32 | $931 | $29 |
| Furosemide | 85 | $918 | $11 |
| Metoprolol | 84 | $836 | $10 |
| Alendronate | 46 | $821 | $18 |
| Lovastatin | 64 | $820 | $13 |
| Oxycodone-Acetaminophen | 12 | $736 | $61 |
| Tamsulosin | 17 | $677 | $40 |
| Clopidogrel | 13 | $643 | $49 |
| Famotidine | 34 | $617 | $18 |
| Adacel Tdap | 14 | $574 | $41 |
| Metronidazole | 13 | $467 | $36 |
| Terazosin | 26 | $443 | $17 |
| Lorazepam | 43 | $434 | $10 |
| Insulin | 12 | $417 | $35 |
| Fluoxetine | 29 | $378 | $13 |
| Naproxen | 20 | $346 | $17 |
| K-Tab Er | 13 | $344 | $26 |
| Temazepam | 18 | $343 | $19 |
| Ibuprofen | 15 | $316 | $21 |
| Nortriptyline | 15 | $301 | $20 |
| Warfarin | 21 | $272 | $13 |
| Fluocinonide | 11 | $260 | $24 |
| Clonidine | 15 | $246 | $16 |
| Carvedilol | 20 | $225 | $11 |
| Trazodone | 23 | $214 | $9 |
| Zolpidem | 19 | $176 | $9 |
| Azithromycin | 15 | $166 | $11 |
| Ciprofloxacin | 19 | $156 | $8 |
| Sulfamethoxazole-Trimethoprim | 12 | $151 | $13 |
| Meloxicam | 12 | $130 | $11 |
| Diazepam | 12 | $105 | $9 |
| Levofloxacin | 11 | $102 | $9 |
2013: 56 drugs
| Zostavax | 64 | $11,392 | $178 |
| Spiriva | 28 | $10,117 | $361 |
| Atorvastatin | 160 | $5,569 | $35 |
| Aggrenox | 15 | $4,088 | $273 |
| Colcrys | 16 | $3,355 | $210 |
| Levothyroxine | 117 | $3,019 | $26 |
| Pravastatin | 53 | $3,016 | $57 |
| Simvastatin | 125 | $2,787 | $22 |
| Amlodipine Besylate | 127 | $2,757 | $22 |
| Hydrocodone-Acetaminophen | 136 | $2,598 | $19 |
| Hydralazine | 48 | $2,580 | $54 |
| Gabapentin | 23 | $2,463 | $107 |
| Omeprazole | 60 | $2,435 | $41 |
| Losartan | 79 | $2,376 | $30 |
| Atenolol | 185 | $2,251 | $12 |
| Allopurinol | 53 | $2,105 | $40 |
| Lisinopril | 156 | $1,871 | $12 |
| Klor-Con 8 | 16 | $1,859 | $116 |
| Qvar | 22 | $1,724 | $78 |
| Fluticasone Propionate | 67 | $1,618 | $24 |
| Etodolac | 17 | $1,452 | $85 |
| Pantoprazole | 36 | $1,421 | $39 |
| Hydrochlorothiazide | 126 | $1,374 | $11 |
| Lovastatin | 82 | $1,069 | $13 |
| Furosemide | 88 | $1,024 | $12 |
| Lisinopril-Hydrochlorothiazide | 84 | $1,010 | $12 |
| Fenofibrate | 11 | $1,000 | $91 |
| Losartan-Hydrochlorothiazide | 22 | $914 | $42 |
| Morphine Sulfate Er | 15 | $906 | $60 |
| Acetaminophen-Codeine | 35 | $869 | $25 |
| Metformin | 76 | $866 | $11 |
| Alendronate | 55 | $820 | $15 |
| Glipizide | 62 | $789 | $13 |
| Clopidogrel | 11 | $743 | $68 |
| Proair Hfa | 24 | $722 | $30 |
| Lorazepam | 58 | $669 | $12 |
| Temazepam | 25 | $646 | $26 |
| Metoprolol | 60 | $645 | $11 |
| Famotidine | 36 | $644 | $18 |
| Terazosin | 33 | $516 | $16 |
| Ibuprofen | 27 | $492 | $18 |
| Montelukast | 15 | $414 | $28 |
| Clonidine | 14 | $398 | $28 |
| K-Tab Er | 13 | $381 | $29 |
| Trazodone | 35 | $346 | $10 |
| Fluoxetine | 24 | $293 | $12 |
| Naproxen | 11 | $288 | $26 |
| Warfarin | 19 | $223 | $12 |
| Ciprofloxacin | 27 | $205 | $8 |
| Prednisone | 12 | $155 | $13 |
| Nortriptyline | 11 | $155 | $14 |
| Carvedilol | 12 | $140 | $12 |
| Meloxicam | 14 | $138 | $10 |
| Zolpidem | 15 | $132 | $9 |
| Atenolol-Chlorthalidone | 11 | $118 | $11 |
| Sulfamethoxazole-Trimethoprim | 14 | $108 | $8 |
Professional record
- NPI
- 1003096777
- Licence
- CA A101750California A101750: Current · expires 2027-03-31
- Group
- University of California San Francisco · Regents of the University of California
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 11 Cranfield Ave, San Carlos, CA, 94070
- NPI first listed
- 2007-11-09
- NPI last updated
- 2022-01-11
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.